OPX Biotechnologies Advances Acrylic Acid Platform

OPX Biotechnologies, a Boulder, CO-based industrial biotechnology firm, says it reached several key development milestones with its acrylic acid production process in 2011 and will begin moving into demonstration-scale production in the first half of 2012. Proving a cost advantage and securing a big-name chemical partner are vital for any biobased chemical start-up looking to scale-up production, and OPX managed to do both this year. In April, the company signed a joint development agreement with Dow Chemical, the largest U.S. producer of acrylic acid and the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers